Wang Wuji, Wang Honglan, Luo Yang, Li Zheng, Li Jingjie
Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi, 563006, China; Key Laboratory of Basic Pharmacology of Guizhou Province, Zunyi Medical University, Zunyi, 563006, China; Department of Pharmacology, School of Pharmacy, Zunyi Medical University, Zunyi, 563006, China.
Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi, 563006, China; Key Laboratory of Basic Pharmacology of Guizhou Province, Zunyi Medical University, Zunyi, 563006, China; Department of Pharmacology, School of Pharmacy, Zunyi Medical University, Zunyi, 563006, China.
J Ethnopharmacol. 2024 Oct 28;333:118405. doi: 10.1016/j.jep.2024.118405. Epub 2024 Jun 4.
Ecliptea herba, a traditional Chinese herbal medicine for hair loss, was first recorded in the Tang Dynasty's 'Qian Jin Yue Ling', of which the active ingredients and mechanisms of action in the treatment of chemotherapy-induced hair loss remain poorly investigated.
To investigate the effects of the petroleum ether extract of Eclipta (PEE) on alopecia and follicle damage and elucidate its potential therapeutic mechanisms using the integration of network pharmacology, bioinformatics, and experimental validation.
UPLC-MS was used to analyse the chemical composition of PEE. A network pharmacology approach was employed to establish the 'components-targets-pathways' network of PEE to explore potential therapeutic pathways and targets. Molecular docking was used for validation, and the mechanism of PEE in treating chemotherapy-induced alopecia (CIA) was elucidated using in vitro and in vivo on CIA models.
UPLC-MS analysis of PEE revealed 185 components, while network pharmacology and molecular docking analyses revealed potential active compounds and their target molecules, suggesting the involvement of core genes, such as TP53, ESR1, AKT1, IL6, TNF, and EGFR. The key components included wedelolactone, dimethyl-wedelolactone, luteoloside, linarin, and hispidulin. In vivo, PEE promoted hair growth, restored the number of hair follicles, and reduced follicle apoptosis. Conversely, in vitro, PEE enhanced cell viability, reduced apoptosis, and protected HaCaT cells from damage induced by 4-hydroperoxycyclophosphamide (4-HC).
PEE alleviated hair follicle damage in CIA mice by inhibiting the P53/Fas pathway, which may be associated with inhibiting hair follicle cell apoptosis. This study provides a novel therapeutic strategy for treating cyclophosphamide-induced hair loss.
墨旱莲,一种用于治疗脱发的传统中草药,最早记载于唐代的《千金月令》,其治疗化疗引起脱发的活性成分和作用机制仍研究不足。
研究墨旱莲石油醚提取物(PEE)对脱发和毛囊损伤的影响,并通过网络药理学、生物信息学和实验验证相结合的方法阐明其潜在治疗机制。
采用超高效液相色谱-质谱联用技术分析PEE的化学成分。采用网络药理学方法构建PEE的“成分-靶点-通路”网络,以探索潜在的治疗通路和靶点。利用分子对接进行验证,并通过体外和体内化疗诱导脱发(CIA)模型阐明PEE治疗CIA的机制。
PEE的超高效液相色谱-质谱联用分析显示有185种成分,而网络药理学和分子对接分析揭示了潜在的活性化合物及其靶分子,提示核心基因如TP53、ESR1、AKT1、IL6、TNF和EGFR的参与。关键成分包括去甲蟛蜞菊内酯、二甲基去甲蟛蜞菊内酯、木犀草苷、蒙花苷和异鼠李素。在体内,PEE促进头发生长,恢复毛囊数量,并减少毛囊凋亡。相反,在体外,PEE提高细胞活力,减少凋亡,并保护HaCaT细胞免受4-氢过氧环磷酰胺(4-HC)诱导的损伤。
PEE通过抑制P53/Fas通路减轻CIA小鼠的毛囊损伤,这可能与抑制毛囊细胞凋亡有关。本研究为治疗环磷酰胺诱导的脱发提供了一种新的治疗策略。